1. Home
  2. UG vs ITRM Comparison

UG vs ITRM Comparison

Compare UG & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • ITRM
  • Stock Information
  • Founded
  • UG 1942
  • ITRM 2015
  • Country
  • UG United States
  • ITRM Ireland
  • Employees
  • UG N/A
  • ITRM N/A
  • Industry
  • UG Package Goods/Cosmetics
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • UG Consumer Discretionary
  • ITRM Health Care
  • Exchange
  • UG Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • UG 36.4M
  • ITRM 40.0M
  • IPO Year
  • UG N/A
  • ITRM 2018
  • Fundamental
  • Price
  • UG N/A
  • ITRM $0.76
  • Analyst Decision
  • UG
  • ITRM Strong Buy
  • Analyst Count
  • UG 0
  • ITRM 1
  • Target Price
  • UG N/A
  • ITRM $9.00
  • AVG Volume (30 Days)
  • UG 7.1K
  • ITRM 770.5K
  • Earning Date
  • UG 11-07-2025
  • ITRM 11-13-2025
  • Dividend Yield
  • UG 9.22%
  • ITRM N/A
  • EPS Growth
  • UG N/A
  • ITRM N/A
  • EPS
  • UG 0.56
  • ITRM N/A
  • Revenue
  • UG $10,856,174.00
  • ITRM N/A
  • Revenue This Year
  • UG N/A
  • ITRM N/A
  • Revenue Next Year
  • UG N/A
  • ITRM $482.25
  • P/E Ratio
  • UG $13.49
  • ITRM N/A
  • Revenue Growth
  • UG N/A
  • ITRM N/A
  • 52 Week Low
  • UG $7.50
  • ITRM $0.61
  • 52 Week High
  • UG $15.05
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • UG 41.08
  • ITRM 57.69
  • Support Level
  • UG $7.50
  • ITRM $0.66
  • Resistance Level
  • UG $8.09
  • ITRM $0.83
  • Average True Range (ATR)
  • UG 0.25
  • ITRM 0.05
  • MACD
  • UG -0.03
  • ITRM 0.01
  • Stochastic Oscillator
  • UG 3.47
  • ITRM 59.18

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: